Physician profile
Manuel Grinberg
NPI 1114928967
$4,065.68
in general payments reported to CMS, 2019-2025
30 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $719 · 2020: $124 · 2021: $580 · 2022: $749 · 2023: $862 · 2024: $650 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,804 · Education: $89.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,803.81 |
| Education | $89.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $903.85 | 2019-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $621.43 | 2019-2025 | |
| Astellas Pharma US INC | $508.28 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $315.03 | 2019-2024 | Provenge |
| Sumitomo Pharma America, INC. | $246.79 | 2023-2025 | Orgovyx, Gemtesa |
| Myovant Sciences INC. | $170.75 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $160.41 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $156.14 | 2019-2024 | |
| Urovant Sciences INC | $121.47 | 2021-2022 | |
| Coloplast Corp | $113.21 | 2021-2024 | Speedicath |
| Tolmar Pharmaceuticals, INC. | $100.56 | 2019-2022 | |
| Teleflex LLC | $73.06 | 2022-2023 | Urolift |
| Pfizer INC. | $66.35 | 2019-2022 | |
| Hollister Incorporated | $55.05 | 2021-2023 | Vapro, Infyna Chic, Onli |
| Progenics Pharmaceuticals, INC. | $53.65 | 2022-2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $53.05 | 2019-2024 | Varithena Administration Pack |
| Urogen Pharma, INC. | $48.75 | 2022-2025 | |
| 180 Medical, INC. | $34.28 | 2023 | |
| Telix Pharmaceuticals | $29.53 | 2024 | Illuccix |
| Abc Home Medical Supply, INC. | $25.76 | 2024 | |
| Olympus America INC. | $25.50 | 2025 | Itind System |
| Jazz Pharmaceuticals INC. | $24.84 | 2020 | |
| Blue Earth Diagnostics | $23.76 | 2022 | |
| Allergan, INC. | $23.34 | 2022 | |
| Tolmar, INC. | $21.62 | 2024 | |
| Accord Healthcare, INC. | $21.50 | 2025 | |
| Mimedx Group, INC. | $21.42 | 2024 | |
| Endo USA, INC. | $17.03 | 2025 | Xiaflex, Aveed |
| Dentsply Ih INC. | $16.57 | 2021 | |
| Clarus Therapeutics INC. | $12.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Grinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.